Transgene Email Format
Biotechnology ResearchGrand Est, France51-200 Employees
Transgene is a clinical-stage biotechnology company based in Illkirch-Graffenstaden, in the Grand Est region of France, focused on cancer immunotherapy. It develops individualized therapeutic vaccines intended to tailor treatment to the molecular profile of each patient's cancer. Operating in the biotechnology research sector, it seeks to advance personalized vaccine approaches as a modality for cancer treatment. The company is mid-sized and is publicly listed on Euronext under the ticker TNG.